Display options
Share it on

J Cardiovasc Dev Dis. 2021 May 15;8(5). doi: 10.3390/jcdd8050057.

Sympathetic Activation and Arrhythmogenesis after Myocardial Infarction: Where Do We Stand?.

Journal of cardiovascular development and disease

Konstantinos C Zekios, Eleni-Taxiarchia Mouchtouri, Panagiotis Lekkas, Dimitrios N Nikas, Theofilos M Kolettis

Affiliations

  1. 1st Department of Cardiology, University Hospital of Ioannina, 1 St. Niarxou Avenue, 45500 Ioannina, Greece.
  2. Department of Cardiology, University of Ioannina, 1 St. Niarxou Avenue, 45500 Ioannina, Greece.
  3. Cardiovascular Research Institute, 1 St. Niarxou Avenue, 45500 Ioannina, Greece.

PMID: 34063477 PMCID: PMC8156099 DOI: 10.3390/jcdd8050057

Abstract

Myocardial infarction often leads to progressive structural and electrophysiologic remodeling of the left ventricle. Despite the widespread use of β-adrenergic blockade and implantable defibrillators, morbidity and mortality from chronic-phase ventricular tachyarrhythmias remains high, calling for further investigation on the underlying pathophysiology. Histological and functional studies have demonstrated extensive alterations of sympathetic nerve endings at the peri-infarct area and flow-innervation mismatches that create a highly arrhythmogenic milieu. Such accumulated evidence, along with the previously well-documented autonomic dysfunction as an important contributing factor, has stirred intense research interest for pharmacologic and non-pharmacologic neuromodulation in post-infarction heart failure. In this regard, aldosterone inhibitors, sacubitril/valsartan and sodium-glucose cotransporter type 2 inhibitors have shown antiarrhythmic effects. Non-pharmacologic modalities, currently tested in pre-clinical and clinical trials, include transcutaneous vagal stimulation, stellate ganglion modulation and renal sympathetic denervation. In this review, we provide insights on the pathophysiology of ventricular arrhythmogenesis post-myocardial infarction, focusing on sympathetic activation.

Keywords: myocardial infarction; sympathetic activation; ventricular tachyarrhythmias

References

  1. J Basic Clin Physiol Pharmacol. 2018 Jul 26;29(4):339-345 - PubMed
  2. Circ Res. 2004 Jul 9;95(1):76-83 - PubMed
  3. Compr Physiol. 2015 Sep 20;5(4):1877-909 - PubMed
  4. J Cell Mol Med. 2017 Nov;21(11):2695-2710 - PubMed
  5. Circ Arrhythm Electrophysiol. 2015 Feb;8(1):174-85 - PubMed
  6. ESC Heart Fail. 2021 Feb;8(1):222-237 - PubMed
  7. J Mol Cell Cardiol. 2014 Dec;77:147-54 - PubMed
  8. J Mol Cell Cardiol. 1993 May;25(5):563-75 - PubMed
  9. Exp Biol Med (Maywood). 2006 Apr;231(4):387-95 - PubMed
  10. World J Exp Med. 2018 Aug 30;8(1):8-11 - PubMed
  11. Circ Res. 2017 Jun 9;120(12):1969-1993 - PubMed
  12. Circulation. 2000 Jun 27;101(25):2981-8 - PubMed
  13. Lancet. 2019 Jan 5;393(10166):31-39 - PubMed
  14. J Mol Cell Cardiol. 2020 Feb;139:201-212 - PubMed
  15. J Am Coll Cardiol. 2017 Jun 27;69(25):3070-3080 - PubMed
  16. Am J Physiol Heart Circ Physiol. 2002 Jul;283(1):H423-33 - PubMed
  17. N Engl J Med. 2003 Apr 3;348(14):1309-21 - PubMed
  18. Auton Neurosci. 2011 Oct 28;164(1-2):13-9 - PubMed
  19. J Cardiol. 2018 May;71(5):471-476 - PubMed
  20. BMC Cardiovasc Disord. 2013 Jul 13;13:52 - PubMed
  21. CJC Open. 2019 Jun 08;1(4):182-189 - PubMed
  22. Auton Neurosci. 2017 Jul;205:1-11 - PubMed
  23. Eur Heart J. 2004 Apr;25(7):551-7 - PubMed
  24. Hypertension. 1986 Feb;8(2):133-41 - PubMed
  25. N Engl J Med. 1999 Sep 2;341(10):709-17 - PubMed
  26. Circulation. 1987 Apr;75(4):877-87 - PubMed
  27. Herzschrittmacherther Elektrophysiol. 2011 Dec;22(4):243-8 - PubMed
  28. Circ Res. 2016 Jun 24;119(1):91-112 - PubMed
  29. Neurology. 1986 Aug;36(8):1067-73 - PubMed
  30. Pacing Clin Electrophysiol. 2007 Jan;30(1):115-22 - PubMed
  31. Heart Rhythm. 2020 Feb;17(2):220-227 - PubMed
  32. Biomed Res Int. 2015;2015:591708 - PubMed
  33. Eur J Heart Fail. 2003 Oct;5(5):659-67 - PubMed
  34. Basic Res Cardiol. 2000;95 Suppl 1:I41-5 - PubMed
  35. Circ Res. 2015 Jun 5;116(12):2005-19 - PubMed
  36. Circ Cardiovasc Interv. 2017 Mar;10(3):e004172 - PubMed
  37. Am J Physiol Heart Circ Physiol. 2004 Jun;286(6):H2229-36 - PubMed
  38. J Electrocardiol. 2015 May-Jun;48(3):434-40 - PubMed
  39. Cardiovasc Res. 2005 Apr 1;66(1):22-32 - PubMed
  40. Am J Cardiol. 1997 Nov 13;80(9B):35J-39J - PubMed
  41. Front Physiol. 2019 Mar 11;10:200 - PubMed
  42. Am J Cardiol. 2000 Sep 15;86(6):649-53 - PubMed
  43. J Cardiovasc Pharmacol Ther. 2005 Jun;10 Suppl 1:S15-22 - PubMed
  44. Ann Noninvasive Electrocardiol. 2017 Mar;22(2): - PubMed
  45. Cardiovasc Res. 1999 May;42(2):284-97 - PubMed
  46. Cardiovasc Res. 1993 Nov;27(11):1954-60 - PubMed
  47. J Am Heart Assoc. 2018 Mar 3;7(5): - PubMed
  48. Int J Cardiol Heart Vasc. 2019 Feb 20;22:156-159 - PubMed
  49. Pharmacol Rev. 2020 Jan;72(1):50-79 - PubMed
  50. N Engl J Med. 2014 Sep 11;371(11):993-1004 - PubMed
  51. Curr Pharm Des. 2014;20(12):1925-9 - PubMed
  52. Circulation. 2018 Aug 7;138(6):551-553 - PubMed
  53. JACC Clin Electrophysiol. 2016 Jun;2(3):330-339 - PubMed
  54. EBioMedicine. 2020 Jul;57:102845 - PubMed
  55. J Hypertens. 2017 Oct;35(10):2059-2068 - PubMed
  56. Annu Rev Med. 2018 Jan 29;69:147-164 - PubMed

Publication Types